CD16 sdAb was derived from a published llama sdAb (GeneBank sequence EF561291). The CD16 sdAb was spliced to CD19 to test the ability of this CD16 engager to drive NK cell killing. The CD16 sdAb showed cytolytic NK activity similar to rituximab-mediated killing in a chromium release assay with CD19+Raji targets.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-2138z | Mouse Anti-IL16 Recombinant Antibody (clone 27G12) | WB, ELISA, FC, ICC, IF, IHC | Mouse IgG1 |
ZG-0495J | Mouse Anti-IL16 Recombinant Antibody (ZG-0495J) | WB, ELISA | Mouse IgG |
VS3-XY855 | Mouse Anti-IL16 Recombinant Antibody (clone 5D8) | ELISA, WB | Mouse IgG1 |
VS3-WK1718 | Recombinant Rabbit Anti-IL16 Capture Antibody (clone R04-6D1) | ELISA | Rabbit IgG |
VS3-WK1719 | Recombinant Rabbit Anti-IL16 Detection Antibody (clone R08-8E1) | ELISA | Rabbit IgG |
There are currently no Customer reviews or questions for HPAB-N0308-YC-VHH. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.